Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.CITIES.2022.104102 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Research examining built environment (BE) characteristics and walking/cycling behaviors has been conducted primarily in high-income countries and conclusions cannot be applied directly to low-and middle-income countries. We evaluated perceived BE characteristics and walking/cycling behaviors across 355 urban commu-nities in 21 low-, middle-, and high-income countries using individual data for 39,908 adults in the Prospective Urban and Rural Epidemiology study. The 1-week long-form International Physical Activity Questionnaire was used to measure walking/cycling behaviors. Perceived BE characteristics were measured using the Neighborhood Environment Walkability Scale. Mixed effects logistic regression models examined associations between BE measures and walking for transport (>= 150 min/wk), walking for leisure (>= 150 min/wk), and any cycling for transport, controlling for individual, household, and community factors. Land-use mix diversity, land-use mix access, and street connectivity were associated with higher odds of walking for transport. Land-use mix diversity, land-use mix access, safety from traffic and safety from crime were associated with higher odds of walking for leisure. Land-use mix diversity, land-use mix access, and aesthetics were associated with higher odds of cycling. Differences in associations were observed by country-income status. Our findings can help guide policy makers globally to implement BE design to encourage walking and cycling behaviors.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Boakye, Kwadwo | - |
Calif State Univ Chico - Estados Unidos
California State University, Chico - Estados Unidos |
| 2 | Bovbjerg, Marit | Mujer |
Oregon State Univ - Estados Unidos
Oregon State University - Estados Unidos |
| 3 | Schuna Jr, John | Hombre |
Oregon State Univ - Estados Unidos
Oregon State University - Estados Unidos |
| 4 | Branscum, Adam | Hombre |
Oregon State Univ - Estados Unidos
Oregon State University - Estados Unidos |
| 5 | Nasir, Nafiza Mat | - |
Univ Teknol Mara - Malasia
Universiti Teknologi Mara - Malasia |
| 6 | Puri, Raman | Hombre |
Isfahan Univ Med Sci - Iran
Isfahan Cardiovascular Research Center, Isfahan UMS - Iran Queens Univ - Canadá Queen’s University - Canadá Univ Ottawa - Canadá L'Hôpital d'Ottawa - Canadá |
| 7 | Barbarash, Olga L. | Mujer |
Fed State Budgetary Inst Res Inst Complex Issues - Rusia
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases” (NII KPSSZ) - Rusia |
| 8 | Yusuf, Rita | Mujer |
Independent Univ - Bangladesh
University of Dhaka - Bangladesh |
| 9 | López-Jaramillo, Patricio | Hombre |
Univ Santander UDES - Colombia
Universidad de Santander - Colombia |
| 10 | SERON-SILVA, PAMELA JEANNETTE | Mujer |
Universidad de La Frontera - Chile
|
| 11 | Rosengren, Annika | Mujer |
Univ Gothenburg - Suecia
Sahlgrens Univ Hosp - Suecia Sahlgrenska Akademin - Suecia Sahlgrenska Universitetssjukhuset - Suecia |
| 12 | Puri, Raman | Hombre |
Isfahan Univ Med Sci - Iran
Isfahan Cardiovascular Research Center, Isfahan UMS - Iran Queens Univ - Canadá Queen’s University - Canadá Univ Ottawa - Canadá L'Hôpital d'Ottawa - Canadá |
| 13 | Chifamba, Jephat | - |
Univ Zimbabwe - Zimbabue
University of Zimbabwe - Zimbabue |
| 14 | AlHabib, Khalid F. | Hombre |
King Saud Univ - Arabia Saudí
King Saud University - Arabia Saudí |
| 15 | Davletov, Kairat | Hombre |
Al Farabi Kazakh Natl Univ - Kazajistán
Al Farabi Kazakh National University - Kazajistán |
| 16 | Keskinler, Mirac V. | - |
Istanbul Medeniyet Univ - Turquía
Istanbul Medeniyet University - Turquía |
| 17 | Diaz, Maria | Mujer |
Inst Cardiovasc Rosario - Argentina
INSTITUTO CARDIOVASCULAR DE ROSARIO - Argentina |
| 18 | Kruger, I | - |
North West Univ - República de Sudáfrica
North-West University - República de Sudáfrica |
| 19 | Li, Yang | - |
Peking Union Med College& Chinese Acad Med Sci - China
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College - China |
| 20 | Zhiguang, Liu | - |
Capital Med Univ - China
Beijing Anzhen Hospital, Capital Medical University - China |
| 21 | Tse, Lap Ah | Hombre |
Chinese Univ Hong Kong - China
Chinese University of Hong Kong - Hong Kong |
| 22 | Puri, Raman | Hombre |
Isfahan Univ Med Sci - Iran
Isfahan Cardiovascular Research Center, Isfahan UMS - Iran Queens Univ - Canadá Queen’s University - Canadá Univ Ottawa - Canadá L'Hôpital d'Ottawa - Canadá |
| 23 | Teo, Koon | - |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Hamilton Health Sciences - Canadá |
| 24 | Erkin, Mirrakhimov | - |
Kyrgyz State Med Acad - Kirguizistán
Kyrgyz State Medical Academy - Kirguizistán |
| 25 | Rangarajan, Sumathy | Mujer |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Hamilton Health Sciences - Canadá |
| 26 | Lear, Scott | Hombre |
Simon Fraser Univ - Canadá
Simon Fraser University - Canadá |
| 27 | Yusuf, Salim | Hombre |
MCMASTER UNIV - Canadá
Hamilton Hlth Sci - Canadá Hamilton Health Sciences - Canadá |
| 28 | Hystad, Perry | Hombre |
Oregon State Univ - Estados Unidos
Oregon State University - Estados Unidos |
| 29 | Prospective Urban & Rural Epidemiological PURE Study Investigators | Corporación |
| Fuente |
|---|
| Canadian Institutes of Health Research |
| Office of the Director, National Institutes of Health |
| Population Health Research Institute |
| Boehringer Ingelheim (Canada) |
| Ontario Ministry of Health and Long-Term Care |
| Boehringer Ingelheim (Germany) |
| AstraZeneca (Canada) |
| Canadian Institutes for Health Research |
| Sanofi-Aventis (France and Canada) |
| Heart and Stroke Foundation (ON, Canada) |
| Hamilton Health Sciences Research Institute |
| Agradecimiento |
|---|
| The PURE study is funded by the Population Health Research Institute, Hamilton Health Sciences Research Institute, the Canadian Institutes of Health Research (including through the Strategy for Patient -Oriented Research via the Ontario SPOR Support Unit), the Heart and Stroke Foundation (ON, Canada), the Ontario Ministry of Health and Long-Term Care. The PURE-AIR study is funded by the Canadian In-stitutes for Health Research (grant 136893) and by the Office of the Director, National Institutes of Health (award DP5OD019850). It is also funded by unrestricted grants from several pharmaceutical companies, with major contributions from AstraZeneca (Canada), Sanofi-Aventis (France and Canada), Boehringer Ingelheim (Germany and Canada), |